BBP (BBP) Stock Price & Analysis
BBP (BBP) fell 0.89% to USD 96.39 as of July 26, 2026 at 19:12 UTC, according to Nexqual real-time market data.
BBP last closed at USD 97.26; the session ranged USD 96.35–96.9 on volume of 1,919 shares. Market capitalization is —, with a 52-week range of USD 60.91–105.21 (PCX). Source: Nexqual, July 26, 2026 at 19:12 UTC.
Key Statistics (as of July 26, 2026 at 19:12 UTC)
| Price | USD 96.39 |
|---|---|
| Change | ▼ 0.89% (down) |
| Previous Close | USD 97.26 |
| Open | USD 96.49 |
| Day Range | USD 96.35 – 96.9 |
| 52-Week Range | USD 60.91 – 105.21 |
| Volume | 1,919 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (BBP)
Nexqual's technical model rates BBP "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 19:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.57 (neutral) |
| vs SMA50 | Above (USD 91.66) |
| MACD | 1.44 (positive) |
Financial Health Score (BBP)
Nexqual rates BBP's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 19:12 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials | USD 49.67 | ▼ 1.87% |
| SBIO | ALPS Medical Breakthroughs ETF | USD 63.77 | ▼ 0.51% |
| FBT | First Trust Amex Biotech Index | USD 247.39 | ▲ 0.9% |
| PBE | Invesco Biotechnology & Genome | USD 89.59 | ▲ 0.28% |
| PSCH | Invesco S&P SmallCap Health Car | USD 52.95 | ▲ 0.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 19:12 UTC. This page is informational and not investment advice.